Characteristic | Considering MLPA based molecular diagnostic performed cases (n = 236) |  | |
---|---|---|---|
 | DMD (n = 138) | BMD (n = 11) | Negative for MLPA (n = 87) |
Age range (Mean) | 1.5–18 Yrs (8 Yrs) | 12–37 Yrs (21 Yrs) | 8–42 Yrs (16 Yrs) |
Age of onset range (Mean) (In our cohort, at the onset patients have received their first clinical evaluation) | 1–8 Yrs (4 Yrs) | 11–15 Yrs (13 Yrs) | 7–18 Yrs (12 Yrs) |
Gender | Male-138: Female-0 | Male-11: Female-0 | Male-84: Female-3 |
Frequent First neurological event at onset | Difficulty in climbing stairs- 49/138 (36%) and Frequent falling- 39/138 (28%) | Calf pain- 3/11 (27%) Difficulty in climbing stairs- 3/11 (27%) and Frequent falling- 3/11 (27%) | Difficulty in climbing stairs- 40/87 (46%) Frequent falling- 22/87 (25%) |
Presence of development delay (Most patients were present with a combination of developmental delays) | 76/138 (55%) Of which; Motor delay- 67/76 (88%) Language delay- 57/76 (75%) Vision & fine motor delay- 30/76 (39%) | No | 4/87 (5%) Of which; Motor delay- 3/4 (75%) Language delay- 2/4 (50%) |
NSAA mean | 14/34 | 21/34 | 23/34 |
CPK Range | 1670–45000 U/L | 916–11,340 U/L | 840–9750 U/L |
Mean CPK | 15,143 U/L* | 4000 U/L* | 4330 |